The Center for Biotechnology and Global Health Policy (CBGHP) serves as a reference point for research, policy development and advocacy concerning science, biotechnology, bioethics and healthcare in the United States and abroad. The CBGHP engages multiple stakeholder communities: scholars, policy makers, civil society, healthcare providers, the judiciary and the general public, highlighting the collaborative role and function of law in responding to state, federal and international healthcare concerns.
Michele Bratcher Goodwin is a Chancellor’s Professor at the University of California, Irvine and founding director of the Center for Biotechnology and Global Health Policy. She is the recipient of the 2020-21 Distinguished Senior Faculty Award for Research, the highest honor bestowed by the University of California. She is also the first law professor at the University of California, Irvine to receive this award. She is an elected member of the American Law Institute as well as an elected Fellow of the American Bar Foundation and the Hastings Center (the organization central to the founding of bioethics). She is an American Law Institute Adviser for the Restatement Third of Torts: Remedies. More about Prof. Goodwin > | VIDEO: About the Center for Biotechnology and Global Health Policy >
Mission:To educate the public and serve as a catalyst for the advancement of society through research, educational outreach and advocacy.
Vision: We strive to make our work accessible for all communities. Starting in 2020-21, all online programming is joined by ASL interpretation.
Activities
The CBGHP prioritizes collaborative, cross-cultural and interdisciplinary exchanges, bringing scholars, policy makers, nongovernmental organization members and others to the University of California, Irvine for roundtables, symposia and points of engagement. We serve as conduit for knowledge at UCI between departments in Health Sciences, Public Health, Stem Cell Research Center, Social Sciences, Law, and the Humanities. More about CBGHP Activities >
Initiatives
The CBGHP engages three major initiatives: Public Health and Legal Policy; Reproductive Justice; and Antiracism, Inclusion and Global Equality. We proudly partner with the Institute for Global Child Advocacy. More about CBGHP Initiatives >
Responding to COVID-19 and Pandemics
The CBGHP has been at the forefront of academic discourse and engagement on COVID-19 through symposia, colloquia, public commentary, and collaboration. This work has garnered national and international attention, during the pandemic. More about CBGHP's COVID-19 Response >
The CBGHP was founded to advance contemporary discourses on biotechnology, bioethics, health, social justice, women’s health, and law. We are meeting this goal and much more through interdisciplinary collaborations with experts and practitioners in the areas of medicine, public health, gender and sexuality studies, and human ecology, to name a few. We are engaging communities through colloquia, symposia, collaborative roundtables and discussion series. Come join us. Hear our stories and tell us yours. More about Our Stories>
Scholarship and Publications
The CBGHP is a centerpoint for engagement with academics, civil society, foundations, the private sector, and government to advance knowledge. Members of its community are highly-sought after and recognized for their achievements in law, health sciences, social sciences, the humanities, and economics. Their works are published in books, the leading peer-reviewed journals, and news outlets domestically and internationally. Members of our community serve on civil society boards and are recruited to advise the public and private sector on health, technology, social determinants of health, and ethics. Their research has received numerous awards. For scholarship, please click here. For news and commentary, please click here.
